Federated Hermes, Inc. Applied Therapeutics Inc. Transaction History

Federated Hermes, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.76 - $2.64 $394 - $1,370	-519 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$1.48 - $6.22 $768 - $3,228	519 New	519 $1,000
Q3 2020 Nov 12, 2020	SELL	$19.43 - $35.36 $929,686 - $1.69 Million	-47,848 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$29.41 - $51.23 $1.16 Million - $2.02 Million	39,478 Added 471.66%	47,848 $1.73 Million
Q1 2020 May 13, 2020	SELL	$19.54 - $55.47 $635,890 - $1.81 Million	-32,543 Reduced 79.54%	8,370 $274,000
Q4 2019 Feb 14, 2020	BUY	$10.16 - $28.14 $415,676 - $1.15 Million	40,913 New	40,913 $1.12 Million

139

114M

1.62M

1.91M

Ticker APLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,700
Market Cap $446M
Description
Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.